Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04435873 · ClinicalTrials.gov registry record
Assessing Patient-Reported Experience of Care for Home Dialysis (ASPIRED)
A clinical trial, sponsored by Satellite Healthcare.
- Completed
- Registry status
- 513
- Enrollment target
NCT04435873: Completed study, sponsored by Satellite Healthcare.
NCT04435873 is a clinical trial that has completed, run by Satellite Healthcare. The registered enrollment target is 513 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04435873 has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- 513 participants
- Enrollment target
Study Summary
Home dialysis modalities, including peritoneal dialysis (PD) and home hemodialysis (HHD), represent alternatives to conventional in-center hemodialysis (HD) that for some patients may be better aligned with preferences regarding the integration of dialysis treatments into their lives. Assessment of patient experience and satisfaction with care among individuals undergoing maintenance dialysis in the United States is a national health care priority and mandated by Congress. While validated instruments (ICH CAHPS) are in use to assess patient experience with in-center HD, currently no validated instruments are available to measure patient-reported experience in home dialysis. This Home Patient Experience Survey Validation Study is an in-house research study conducted in partnership with the University of Washington.
Primary Outcome
The evaluation will encompass the survey burden, presence of a floor or ceiling effect for any item, test-retest reliability, development of multi-item subscales, internal consistency and reliability, center level reliability of the items and composites, and construct validity.
Interventions
- OTHER Survey using "Your Home Dialysis Care Experience" tool.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2020-07-17 |
| Est. Completion | 2021-05-06 |
What the finished NCT04435873 record still lists
NCT04435873 is an observational study that tracks outcomes without assigning an intervention. The registered 513 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey using "Your Home Dialysis Care Experience" tool. is the first listed.
NCT04435873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04435873 about?
NCT04435873 is a clinical study titled "Assessing Patient-Reported Experience of Care for Home Dialysis (ASPIRED)". Home dialysis modalities, including peritoneal dialysis (PD) and home hemodialysis (HHD), represent alternatives to conventional in-center hemodialysis (HD) that for some patients may be better aligned with preferences regarding the integration of dialysis treatments into their lives. Assessment of ...
What is the current status of trial NCT04435873?
This trial is currently completed. The enrollment target is 513 participants. The study started on 2020-07-17. Estimated completion is 2021-05-06.
What interventions are being tested in trial NCT04435873?
The interventions under investigation include: Survey using "Your Home Dialysis Care Experience" tool. (OTHER).
Who is sponsoring clinical trial NCT04435873?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI